Wijnand, Joep G J <br/><br/>
Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemia.  [electronic resource] 

 -  Journal of vascular surgery  02 2018 
 - 656-661 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-6809 
<br/><br/><label>Standard No.: </label>10.1016/j.jvs.2017.09.026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Academic Medical Centers<br/>Clinical Protocols<br/>Critical Illness<br/>Double-Blind Method<br/>Exercise Tolerance<br/>Humans<br/>Injections, Intramuscular<br/>Ischemia--diagnosis<br/>Lower Extremity--blood supply<br/>Mesenchymal Stem Cell Transplantation--adverse effects<br/>Neovascularization, Physiologic<br/>Netherlands<br/>Peripheral Arterial Disease--diagnosis<br/>Recovery of Function<br/>Research Design<br/>Time Factors<br/>Transplantation, Homologous<br/>Treatment Outcome